GlassScriptPhysician profile
Ahtesham Ali
NPI 1356988117
$14,050.68
in general payments reported to CMS, 2019-2025
42 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,856 · 2022: $4,271 · 2023: $3,448 · 2024: $3,475.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,791 · Travel and Lodging: $1,132.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,791.48 |
| Travel and Lodging | $1,131.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,502.51 | 2021-2024 | Spravato |
| Biogen, INC. | $1,379.50 | 2021-2024 | Vumerity, Tysabri, Skyclarys |
| Neurocrine Biosciences, INC. | $1,255.79 | 2021-2024 | Ingrezza, Ongentys |
| Ucb, INC. | $1,137.96 | 2021-2024 | Fintepla, Nayzilam, Briviact |
| Abbvie INC. | $902.90 | 2021-2024 | |
| Argenx US, INC. | $622.55 | 2022-2024 | Vyvgart Hytrulo, Vyvgart |
| Alexion Pharmaceuticals, INC. | $560.79 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $557.51 | 2021-2023 | |
| Medtronic, INC. | $529.04 | 2021-2024 | Percept PC Brainsense |
| Teva Pharmaceuticals USA, INC. | $471.89 | 2021-2024 | Austedo Xr, Austedo |
| Amgen INC. | $381.15 | 2021-2022 | |
| Lundbeck LLC | $341.25 | 2021-2024 | Vyepti |
| Biohaven Pharmaceutical Holding Company LTD. | $330.97 | 2022 | |
| Lilly USA, LLC | $329.96 | 2021-2023 | Emgality, Reyvow |
| Jazz Pharmaceuticals INC. | $319.21 | 2021-2023 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $305.52 | 2022-2024 | Mavenclad |
| Genzyme Corporation | $281.50 | 2021 | |
| Pfizer INC. | $266.82 | 2023-2024 | |
| Sk Life Science, INC. | $256.99 | 2021-2024 | |
| US Oncology Corporate, INC. | $246.49 | 2024 | |
| Neurelis, INC. | $231.95 | 2021-2024 | Valtoco |
| Horizon Therapeutics Plc | $222.60 | 2022-2023 | Uplizna |
| Genentech USA, INC. | $222.27 | 2021-2024 | Ocrevus, Enspryng |
| Amneal Pharmaceuticals LLC | $195.01 | 2023-2024 | Rytary |
| Biotronik INC. | $175.46 | 2021 | |
| Axsome Therapeutics, INC. | $155.20 | 2022-2024 | Sunosi |
| Averitas Pharma INC. | $138.21 | 2024 | Qutenza |
| Kyowa Kirin, INC. | $125.68 | 2021-2023 | Nourianz |
| Harmony Biosciences LLC | $99.57 | 2022-2024 | |
| Philips North America LLC | $65.91 | 2022 | |
| Greenwich Biosciences, INC. | $63.56 | 2021 | |
| Csl Behring | $58.87 | 2022-2023 | Privigen, Hizentra |
| Octapharma USA, INC. | $54.63 | 2021 | |
| Eisai INC. | $49.94 | 2021-2024 | |
| Catalyst Pharmaceuticals, INC. | $41.71 | 2024 | |
| Ge Healthcare | $35.83 | 2024 | |
| Ani Pharmaceuticals, INC. | $33.17 | 2024 | Purified Cortrophin Gel |
| Biohaven Pharmaceuticals, INC. | $31.16 | 2021 | |
| Tg Therapeutics, INC. | $23.00 | 2023 | |
| Ipsen Biopharmaceuticals, INC | $19.21 | 2024 | Dysport |
| Allergan, INC. | $13.91 | 2021 | |
| Grt US Holding, INC. | $13.53 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ahtesham Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.